NLRP3 and Schwartz-Jampel syndrome: Conducting research on the benefits of utilizing MCC950 to suppress the NLRP3 inflammasome in patients with SJS/TEN to see if there are any beneficial outcomes would be novel for future treatments for this fatal disease.